- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Product development with the use of oral drug controlled release technology and current trend
-
- Kondo Hiromu
- Pharmaceutical Research and Technology Labs. Astellas Pharma Inc.
-
- Sako Kazuhiro
- Astellas Ireland Co., Ltd.
Bibliographic Information
- Other Title
-
- 経口コントロールドリリース製剤技術を用いた製品開発と最近の動向
- ケイコウ コントロールドリリース セイザイ ギジュツ オ モチイタ セイヒン カイハツ ト サイキン ノ ドウコウ
Search this article
Description
Drug products with oral drug controlled release technology play a center role in the market of Drug Delivery System (DDS) and greatly contribute to drug therapy. Drug product functions from medical practices are being diversified. Therefore, demands for development of a wide variety of products in small quantities will be forecasted in the pharmaceutical sector. With advance in science, oral drug controlled release technology is being transformed from specialty to commodity. A variety type of oral drug controlled release technologies are found in the world. Bioequivalence to original oral drug controlled release products can be shown with the technologies. In the past, oral drug controlled release technologies have provided not only functional values based on pharmaceutical technologies but also customer values from user needs. Prolongation of pharmacological effect, reduction of dose frequency, prevention of the risk of adverse effects with steep drug absorption, and so on, have been considered as the conventional product values of oral drug controlled release technologies. For the future, novel product values should be alternatively created for oral drug controlled release technology in order to continue contribution to the drug therapy. In this report, current development of the oral drug controlled release formulations is overviewed. New product value creation with oral controlled release technology will be introduced in terms of drug abuse protection, adherence improvement, drug repositioning, and reformulation.
Journal
-
- Drug Delivery System
-
Drug Delivery System 31 (3), 210-218, 2016
THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679619045632
-
- NII Article ID
- 130005433004
-
- NII Book ID
- AN10084591
-
- ISSN
- 18812732
- 09135006
-
- NDL BIB ID
- 027563230
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed